From: A blinded-endpoint, randomized controlled trial of Sanyrene with natural active ingredient for prophylaxis of radiation dermatitis in patients receiving radiotherapy
Group
Grade 1
Grade 2
Grade 3
Control intervention (n = 49)
16(32.7)
23(46.9)
10(20.4)
Sanyrene (n = 50)
39(78.0)
7(14.0)
4(8.0)
p
< 0.001
0.076